Top 24 Diabetes Medication Manufacturing Companies

11
min read
Top 24 Diabetes Medication Manufacturing Companies Main

Top 24 Diabetes Medication Manufacturing Companies

11
min read
Get started
Top 24 Diabetes Medication Manufacturing Companies Main
Inven is a deal sourcing platform that assists you in discovering niche businesses and investors across industries. Our AI-powered database combines millions of company and investor profiles, making it simple to filter, search, and benchmark opportunities. Explore this list as a starting point and connect with us to see how Inven can help you build tailored lists for sourcing and market discovery.

The diabetes medication manufacturing industry is crucial in addressing the global diabetes epidemic. With the rising prevalence of diabetes, companies in this field focus on developing medications that stabilize blood glucose levels, such as insulin and oral hypoglycemic agents. Ranging from large pharmaceutical corporations to specialized manufacturers, these businesses blend innovation with quality control, aiming to enhance patient outcomes. The industry is experiencing increased collaboration with biotech firms, leading to advanced treatments tailored to individual patient needs. Future trends suggest a significant push toward more personalized medicine, integrating technology to manage diabetes effectively.


This list features 24 companies specializing in diabetes medications, each with unique strengths and expertise. They vary in size, from small enterprises to large pharmaceutical corporations, located in various countries including Egypt, Argentina, and India. Founded between 1943 and 2020, these companies have carved out niches in insulin production, diabetes management solutions, and patient education. Many have adopted advanced manufacturing techniques, prioritizing quality and accessibility, thereby addressing the healthcare needs of their respective markets.


Continue reading to discover notable diabetes medication manufacturing companies.


Top 24 Diabetes Medication Manufacturing Companies


1. SEDICO Pharmaceutical

  • Website: sedico.net
  • Ownership type: Private
  • Headquarters: 6Th Of October City, Giza Governorate, Egypt
  • Founded year: 1988
  • Headcount: 1001-5000
  • LinkedIn: sedico-pharmaceutical

SEDICO Pharmaceutical, founded in 1988 by Dr. Ahmed Abou El Enein, is a private pharmaceutical manufacturer based in 6th of October City, Giza Governorate, Egypt. The company specializes in the production of essential medications, with a strong focus on human insulin, which they began producing in 2002. SEDICO has expanded its product line to include over 180 products across various drug groups, showcasing their capability in biotechnology and other pharmaceutical forms. Their manufacturing facilities are among the most advanced in the Middle East, equipped to handle a wide range of pharmaceutical dosage forms. SEDICO's products are distributed globally, reaching healthcare providers and pharmaceutical companies in 30 countries, highlighting their international presence and commitment to meeting healthcare needs.


2. Francelab

  • Website: francelab.com.ar
  • Ownership type: Private
  • Headquarters: Tigre, Buenos Aires, Argentina
  • Employee distribution: Argentina 100%
  • Founded year: 2006
  • Headcount: 11-50
  • LinkedIn: francelab

Francelab, based in Tigre, Buenos Aires, Argentina, is a private pharmaceutical manufacturer established in 2006. The company specializes in the production of medications specifically designed for diabetes treatment, particularly targeting Type 2 diabetes and its complications. With a workforce of approximately 31 employees, Francelab emphasizes high-quality standards in its manufacturing processes. They offer a range of products, including metformin and pioglitazone combinations, which are essential for managing blood sugar levels in diabetic patients. Francelab also provides educational resources for healthcare professionals, enhancing their commitment to diabetes care. Their operations are fully localized in Argentina, ensuring a focused approach to the domestic market.


3. Eli Lilly Sweden AB

  • Website: lilly.se
  • Ownership type: Private
  • Headquarters: Solna, Stockholm, Sweden
  • Employee distribution: Sweden 100%
  • Founded year: 1971
  • Headcount: 51-200
  • LinkedIn: eli-lilly-sweden-ab

Eli Lilly Sweden AB, founded in 1971 and located in Solna, Stockholm, is a pharmaceutical company dedicated to diabetes care. The company specializes in the development and distribution of insulin products and diabetes management solutions aimed at both individuals with diabetes and healthcare providers. Eli Lilly Sweden AB has a rich history in the diabetes sector, having pioneered significant advancements in diabetes treatment. Their product lineup includes various forms of insulin, such as Humalog (insulin lispro) and Humulin NPH, as well as GLP-1 receptor agonists like Trulicity (dulaglutide). The company is committed to research and development, continuously working to enhance treatment options for diabetes patients. With a workforce of approximately 51-200 employees, Eli Lilly Sweden AB operates solely within Sweden, ensuring a focused approach to diabetes care in the region.


4. Prjsc Indar

  • Website: indar.com.ua
  • Ownership type: Private
  • Headquarters: Kyiv, Kyiv, Ukraine
  • Employee distribution: Ukraine 100%
  • Founded year: 1999
  • Headcount: 201-500
  • LinkedIn: indar

Prjsc Indar, based in Kyiv, Ukraine, is a private pharmaceutical manufacturer founded in 1999. The company specializes in the production of insulin and other medications for chronic diseases, particularly targeting the needs of diabetes patients. With a workforce of approximately 201-500 employees, Indar has developed a full technological cycle for producing recombinant human insulin, from raw materials to finished pharmaceutical forms. Over the years, the company has gained recognition for its commitment to quality, evidenced by its adherence to rigorous scientific research and modern production technologies. Indar's products are trusted by patients and healthcare providers not only in Ukraine but also in several countries, including Brazil and Yemen. The company aims to enhance its product offerings to better serve individuals living with diabetes, HIV/AIDS, and tuberculosis, reflecting its dedication to addressing significant health challenges.


5. Geropharm

  • Website: geropharm.com
  • Ownership type: Private
  • Headquarters: St. Petersburg, Florida, United States (USA)
  • Employee distribution: Russia 96%, Other 4%
  • Latest funding: June 2016
  • Founded year: 2001
  • Headcount: 1001-5000
  • LinkedIn: geropharm

Geropharm, founded in 2001, is a private pharmaceutical company based in St. Petersburg, Florida, with a strong operational presence in Russia. The company focuses on developing and manufacturing medicinal products for chronic diseases, particularly diabetes and obesity. Geropharm operates manufacturing facilities in Obolensk and Pushkin, where they produce active pharmaceutical ingredients and finished dosage forms. They have made significant investments in research and development, with over 160 million USD allocated in the last decade to enhance their technological capabilities. Geropharm is recognized for its expertise in diabetology, having achieved a dominant market share in the Russian insulin market. Their product portfolio includes original medications and generics, with a commitment to quality assured through compliance with international standards such as GMP and ISO 9001. The company is also involved in scientific research and has a dedicated R&D center to support its innovative efforts.


6. Denver Farma S.A.


Denver Farma S.A., founded in 1989 and based in Munro, Buenos Aires, Argentina, is a private pharmaceutical company with a workforce of approximately 267 employees. The company specializes in the production of medications and healthcare products, with a notable focus on diabetes treatment. Denver Farma operates a biotechnological plant dedicated to the production of insulin and other therapeutic solutions, showcasing their commitment to innovation and quality in healthcare. Their product line includes Densulin, a human recombinant insulin, and Densulent, the first glargine insulin formulated in Argentina. The company aims to provide high-quality medications at accessible prices, serving healthcare providers, pharmacies, and patients across Argentina.


7. Waterstone Pharmaceuticals, Inc.

  • Website: waterstonepharma.com
  • Ownership type: Venture Capital
  • Headquarters: Carmel, Indiana, United States (USA)
  • Employee distribution: China 100%
  • Latest funding: Other (Debt), $19.0M, September 2012
  • Founded year: 2008
  • Headcount: 501-1000
  • LinkedIn: waterstone-pharmaceuticals-inc.

Waterstone Pharmaceuticals, Inc., based in Carmel, Indiana, was founded in 2008 and specializes in the research and production of medications targeting metabolic diseases, particularly diabetes and kidney disease. The company serves healthcare providers and pharmaceutical businesses by offering innovative drug solutions and high-quality pharmaceutical products. Waterstone has developed a robust drug development and manufacturing operation, focusing on high molecular polymer drug intermediates. They have also received significant funding, including a $19 million debt funding round in 2012, which supports their ongoing research and development efforts. Their commitment to addressing diabetes through advanced pharmaceutical solutions underscores their relevance in the industry.


8. Uniza Group

  • Website: unizagroup.com
  • Ownership type: Private
  • Headquarters: Ahmedabad, Gujarat, India
  • Employee distribution: India 100%
  • Founded year: 2020
  • Headcount: 501-1000
  • LinkedIn: unizagroup

Uniza Group, founded in 2020 and based in Ahmedabad, Gujarat, India, is a private pharmaceutical company that focuses on the manufacturing and distribution of healthcare products. The company is a venture of the Pashupati Group, which has a strong background in textiles. Uniza Group aims to improve the quality of life for patients through innovative healthcare solutions, particularly in the areas of diabetes and cardiovascular diseases. Their product offerings include a range of oral hypoglycemic agents and other medications designed to manage diabetes effectively. The company operates a modern manufacturing facility that adheres to stringent quality standards, ensuring compliance with current good manufacturing practices. Uniza Group is committed to research and development, with a focus on creating a robust product pipeline to meet the needs of healthcare providers and patients alike.


9. Pinnacle Life Science Pvt. Ltd (Subsidiary of Aarti Drugs)


Pinnacle Life Science Pvt. Ltd, a subsidiary of Aarti Drugs, was established in 2014 and is based in Mumbai, Maharashtra, India. The company focuses on the formulation and export of innovative pharmaceutical solutions. With a workforce of around 295 employees, Pinnacle operates with a strong commitment to quality and safety, ensuring compliance with global regulatory standards. Their manufacturing facilities, located in Baddi, Himachal Pradesh, have received US FDA and multiple GMP approvals, allowing them to produce billions of tablets and capsules annually. Pinnacle's product portfolio includes treatments for oncology, cardiovascular health, anti-infectives, and notably, diabetes management. They export to over 90 countries, collaborating with healthcare providers and pharmaceutical companies to deliver effective treatments. Their research and development efforts are geared towards creating new formulations and improving existing ones, reflecting their dedication to addressing critical healthcare needs.


10. Farmindustria S.A.


Farmindustria S.A., operating under the Abbott brand, is a private healthcare company based in the United States, founded in 1956. With a workforce of approximately 367 employees, the company specializes in innovative medical solutions and high-quality pharmaceuticals. Abbott serves a broad customer base, including healthcare providers and consumers, with a strong emphasis on diabetes care. Their product offerings include medications and diagnostic tools designed to help individuals manage diabetes effectively. Abbott's commitment to improving health outcomes is evident in their global operations, which span over 160 countries, focusing on enhancing the quality of life for patients. The company is dedicated to providing reliable and effective treatments, ensuring that people living with diabetes can lead healthier, more active lives.


11. Laboratorios Silanes

  • Website: silanes.com.mx
  • Ownership type: Private
  • Headquarters: Ciudad De Mexico, Ciudad De México, Mexico
  • Employee distribution: Mexico 98%, Other 2%
  • Founded year: 1943
  • Headcount: 201-500
  • LinkedIn: laboratorios-silanes

Laboratorios Silanes, founded in 1943 and based in Mexico City, is a private pharmaceutical company dedicated to the development and commercialization of innovative medications. With a workforce of over 1,000 employees, the company emphasizes high-quality products aimed at addressing significant health challenges, including hypertension, diabetes, and respiratory diseases. Silanes invests heavily in research and development, allocating a notable portion of its annual sales to this area. The company has established a strong presence in the market, with over 50 products available across 15 countries, impacting the lives of more than 3 million patients. Their portfolio includes a recognized range of oral antidiabetic medications, showcasing their commitment to improving health outcomes for individuals with diabetes. Additionally, Silanes has received multiple awards for technological innovation, further underscoring their role in the pharmaceutical industry.


12. Stallion Laboratories pvt. ltd


Stallion Laboratories Pvt. Ltd., founded in 1988 and headquartered in Ahmedabad, Gujarat, India, is a private pharmaceutical formulation manufacturer. The company specializes in producing a wide array of medications, including antidiabetics, antibiotics, and nutritional supplements. Stallion operates with a strong focus on quality and innovation, ensuring that their products meet stringent international standards. They have received WHO GMP and ISO 9001-2015 certifications, which reflect their commitment to maintaining high manufacturing and quality control standards. Stallion's manufacturing facilities are equipped to produce a significant volume of oral solid dosage forms, and they have a robust research and development team dedicated to creating new products. With a presence in more than 50 countries across various regions, Stallion Laboratories plays a vital role in supplying essential medications to healthcare providers and organizations, contributing to patient care globally.


13. Wörwag Pharma GmbH & Co. KG


Wörwag Pharma GmbH & Co. KG, founded in 1971 and based in Germany, is a family-owned pharmaceutical company that specializes in health products. The company is dedicated to managing diabetic complications, nervous system disorders, musculoskeletal issues, and immune system support. With a workforce of over 793 employees, Wörwag Pharma operates in more than 35 countries, providing effective medications and nutritional supplements. Their products are backed by extensive research and development efforts, which include international clinical studies and collaborations with research laboratories. Wörwag Pharma's commitment to addressing diabetic complications, such as diabetic polyneuropathy, highlights their involvement in the diabetes medication sector, making them a notable player in this field.


14. Química Montpellier S.A.


Química Montpellier S.A., founded in 1957 and based in Buenos Aires, Argentina, is a private pharmaceutical company with a workforce of approximately 574 employees. The company specializes in the production of medications aimed at managing diabetes and hypothyroidism. Their product offerings include a variety of antihyperglycemic agents designed to assist patients in controlling their blood sugar levels effectively. Montpellier not only manufactures these medications but also provides educational resources and training programs for healthcare professionals, demonstrating their commitment to improving patient outcomes. The company operates primarily within Argentina, focusing on delivering healthcare solutions tailored to local needs.


15. Procaps

  • Website: procapslaboratorios.com
  • Ownership type: Private
  • Headquarters: Barranquilla, Atlantico, Colombia
  • Employee distribution: Colombia 79%, El Salvador 7%, Bolivia 3%, Other 11%
  • Founded year: 1977
  • Headcount: 5001-10000
  • LinkedIn: procaps

Procaps, founded in 1977 and based in Barranquilla, Colombia, is a private pharmaceutical company with a workforce of approximately 5,000 to 10,000 employees. The company specializes in the development, manufacturing, and marketing of innovative health solutions, including prescription medicines, over-the-counter products, and diabetes management solutions. Their Diabetrics division is specifically dedicated to enhancing the well-being of people with diabetes, showcasing their focus on chronic condition management. Procaps operates in more than 50 markets worldwide, emphasizing quality and innovation in their offerings. The company is committed to maintaining high standards in its operations, adhering to various international quality management systems, and continuously seeking to improve its product portfolio through research and development.


16. Macleods Pharmaceuticals LTD.


Macleods Pharmaceuticals LTD., founded in 1989 and based in Mumbai, Maharashtra, India, is a private pharmaceutical company that develops, manufactures, and markets a wide array of pharmaceutical products. With over 10,000 employees, the company serves healthcare providers, hospitals, and pharmacies, focusing on various therapeutic areas including anti-infectives, cardiovascular, and notably, anti-diabetic medications. Macleods operates multiple manufacturing units and has a strong global distribution network, ensuring their products reach patients across numerous countries. Their research and development efforts are integral to their operations, with dedicated facilities for developing active pharmaceutical ingredients and formulations. The company emphasizes quality and compliance with international regulatory standards, which is crucial in the pharmaceutical industry.


17. Pharm-Holding

  • Website: pharmholding.com
  • Ownership type: Private
  • Headquarters: Saint Petersburg, Saint Petersburg, Russia
  • Employee distribution: Malaysia 100%
  • Founded year: 2011
  • Headcount: 11-50
  • LinkedIn: pharm-holding

Pharm-Holding, based in Saint Petersburg, Russia, is a private pharmaceutical company founded in 2011. It operates as a research and development center under the umbrella of the Geropharm group. The company is dedicated to creating innovative medications and biotechnology products, with a strong emphasis on developing insulin analogs and treatments for chronic diseases. Pharm-Holding has established a comprehensive laboratory complex equipped with advanced technology, enabling them to conduct preclinical and clinical research. Their focus on biotechnology and drug development is evident in their specialized laboratories, which include facilities for genetic engineering and bio-organic chemistry. The company aims to enhance the safety and efficacy of its products, particularly in the diabetes sector, where they are working on a complete line of insulin analogs. This commitment to addressing significant health challenges positions Pharm-Holding as a noteworthy entity in the pharmaceutical industry.


18. Bruno Farmaceutici S.p.A.


Bruno Farmaceutici S.p.A., founded in 1996 and based in Rome, Italy, is a private pharmaceutical company with a workforce of approximately 144 employees. The company specializes in the development, production, and distribution of medications across various therapeutic areas, prominently including diabetes and obesity. Bruno Farmaceutici is recognized for its commitment to improving health outcomes through the provision of essential drugs for chronic disease management. Their product offerings in the diabetes sector include well-known medications such as Metformin and Sitagliptin, which are critical for managing blood sugar levels in diabetic patients. The company has also expanded its reach into international markets, enhancing its presence in the European pharmaceutical landscape. With a focus on quality and safety, Bruno Farmaceutici continues to invest in research and development to innovate and improve its product line, particularly in the diabetes treatment space.


19. Althera

  • Website: altherapharma.com
  • Ownership type: Private
  • Headquarters: Swords, Dublin, Ireland
  • Employee distribution: India 94%, United States (USA) 2%, France 2%, Other 2%
  • Founded year: 2010
  • Headcount: 51-200
  • LinkedIn: althera

Althera Pharmaceuticals, founded in 2010 and based in Swords, Dublin, Ireland, is a private pharmaceutical company dedicated to improving patient health through innovative medicines. The company specializes in the development and supply of oral medications targeting cardiovascular and diabetes-related diseases. Althera's product portfolio includes approved medications like Rosuvastatin/Ezetimibe and Atorvastatin/Ezetimibe, which are available in multiple global markets. The company is actively engaged in research and development, focusing on cardiometabolic therapies, including diabetes management. Althera collaborates with healthcare providers and organizations to enhance treatment options, demonstrating a commitment to making effective therapies accessible to patients worldwide. With a workforce of around 94 employees, primarily located in India, Althera continues to invest in proprietary technologies to deliver affordable and efficacious medications.


20. Ultra Medica Pharmaceutical Industries

  • Website: ultra-medica.org
  • Ownership type: Private
  • Headquarters: Damascus, Damascus Governorate, Syria
  • Employee distribution: Syria 89%, Iraq 11%
  • Founded year: 1955
  • Headcount: 501-1000
  • LinkedIn: ultramedica-pharma

Ultra Medica Pharmaceutical Industries, founded in 1955, is a private pharmaceutical company based in Damascus, Syria. The company specializes in the manufacturing and distribution of a wide range of medications, including antibiotics, cardiovascular drugs, and notably, antidiabetic medications. Ultra Medica is committed to maintaining high standards of quality and compliance with international regulations, which is evident in their adherence to Good Manufacturing Practices (GMP) and various ISO certifications. The company operates multiple production lines, including those for tablets, capsules, and oral liquids, and has developed over 62 in-house drugs targeting various health conditions, including diabetes. With a workforce of around 115 employees, Ultra Medica has positioned itself as one of the prominent pharmaceutical companies in Syria, focusing on both local and regional markets.


21. Chemi Darou Industrial Company


Chemi Darou Industrial Company, established in 1965, is a private pharmaceutical manufacturer located in Tehran, Iran. The company specializes in the production of a wide range of medications and chemical products, serving both healthcare providers and consumers. With a workforce of over 5,000 employees, Chemi Darou emphasizes quality and adherence to international standards in its operations. The company has a significant focus on research and development, ensuring that its products meet the evolving needs of the healthcare market. Among its offerings are medications for various health issues, including diabetes, where they produce empagliflozin and a combination product of empagliflozin and linagliptin. This positions Chemi Darou as a relevant player in the diabetes medication manufacturing sector, contributing to the health and well-being of patients in Iran and potentially beyond.


22. AlphaPharma_KSA

  • Website: alphapharma.com.sa
  • Ownership type: Private
  • Headquarters: King Abdullah Economic City, Makkah, Saudi Arabia
  • Employee distribution: Saudi Arabia 98%, Other 2%
  • Founded year: 2017
  • Headcount: 201-500
  • LinkedIn: alphapharma

AlphaPharma_KSA, founded in 2017 and located in King Abdullah Economic City, Makkah, Saudi Arabia, is a private pharmaceutical manufacturer. The company specializes in producing high-quality medications and health solutions, with a product range that includes anti-diabetics, antiemetics, and cardiology medications. AlphaPharma is dedicated to ensuring the safety and efficacy of its products, adhering to stringent manufacturing practices. Their production facility is equipped with modern technology and is certified by the Saudi Food and Drug Authority (SFDA) for Good Manufacturing Practices (cGMP). The company aims to meet both national and regional healthcare demands, positioning itself as a significant player in the pharmaceutical industry. AlphaPharma's commitment to quality is reflected in its robust quality management systems and ongoing improvements in production processes.


23. Servier Polska

  • Website: servier.pl
  • Ownership type: Private
  • Headquarters: Warsaw, Masovian Voivodeship, Poland
  • Employee distribution: Poland 96%, Ukraine 4%
  • Founded year: 1992
  • Headcount: 501-1000
  • LinkedIn: servierpolska

Servier Polska, established in 1992 and based in Warsaw, is a private pharmaceutical company that specializes in the production of prescription medications. The company operates in several therapeutic areas, including cardiology, oncology, and notably, diabetes. Servier Polska serves healthcare professionals, patients, and pharmacies, ensuring access to essential medications for chronic health conditions. With a workforce of approximately 500 to 1000 employees, the company is primarily focused on the Polish market, with a small presence in Ukraine. Their commitment to research and development is evident, as they invest significantly in the quality and safety of their products, including those for diabetes management. Servier Polska is part of the larger Servier Group, which emphasizes ethical practices and sustainable development in its operations.


24. Atrogi

  • Website: atrogi.com
  • Ownership type: Venture Capital
  • Headquarters: Stockholm, Stockholm, Sweden
  • Employee distribution: Sweden 100%
  • Latest funding: $8.9M, June 2020
  • Founded year: 2013
  • Headcount: 1-10
  • LinkedIn: atrogi

Atrogi, founded in 2013 and based in Stockholm, Sweden, is a biotech company dedicated to addressing the challenges of type 2 diabetes through innovative treatments. The company is currently developing ATR-258, a drug candidate that aims to manage blood glucose levels without the need for insulin. This unique mechanism of action could potentially transform the treatment landscape for individuals with type 2 diabetes. Atrogi operates with a small team of experts, leveraging their extensive experience in research and development to bring their pharmaceutical solutions to market. The company has attracted significant funding, including a recent amount of approximately 8.91 million USD, which supports their ongoing research initiatives. Atrogi's commitment to developing effective treatments for diabetes positions them as a noteworthy entity in the pharmaceutical industry.



Diabetes Medication Manufacturing Insights: Key Companies


CompanyHeadquarterSizeFoundedOwnership
SEDICO Pharmaceutical6Th Of October City, Giza Governorate, Egypt1001-50001988Private
FrancelabTigre, Buenos Aires, Argentina11-502006Private
Eli Lilly Sweden ABSolna, Stockholm, Sweden51-2001971Private
Prjsc IndarKyiv, Kyiv, Ukraine201-5001999Private
GeropharmSt. Petersburg, Florida, United States (USA)1001-50002001Private
Denver Farma S.A.Munro, Buenos Aires, Argentina201-5001989Private
Waterstone Pharmaceuticals, Inc.Carmel, Indiana, United States (USA)501-10002008Venture Capital
Uniza GroupAhmedabad, Gujarat, India501-10002020Private
Pinnacle Life Science Pvt. Ltd (Subsidiary of Aarti Drugs)Mumbai, Maharashtra, India1001-50002014Private
Farmindustria S.A.United States (USA)1001-50001956Private
Laboratorios SilanesCiudad De Mexico, Ciudad De México, Mexico201-5001943Private
Stallion Laboratories pvt. ltdAhmedabad, Gujarat, India10001+1988Private
Wörwag Pharma GmbH & Co. KGGermany1001-50001971Family Owned
Química Montpellier S.A.Buenos Aires, Buenos Aires, Argentina501-10001957Private
ProcapsBarranquilla, Atlantico, Colombia5001-100001977Private
Macleods Pharmaceuticals LTD.Mumbai, Maharashtra, India10001+1989Private
Pharm-HoldingSaint Petersburg, Saint Petersburg, Russia11-502011Private
Bruno Farmaceutici S.p.A.Rome, Lazio, Italy51-2001996Private
AltheraSwords, Dublin, Ireland51-2002010Private
Ultra Medica Pharmaceutical IndustriesDamascus, Damascus Governorate, Syria501-10001955Private
Chemi Darou Industrial CompanyTehran, Tehran, Iran5001-100001965Private
AlphaPharma_KSAKing Abdullah Economic City, Makkah, Saudi Arabia201-5002017Private
Servier PolskaWarsaw, Masovian Voivodeship, Poland501-10001992Private
AtrogiStockholm, Stockholm, Sweden1-102013Venture Capital


Want to Find More Diabetes Medication Manufacturing Companies?

If you want to find more companies that offering insulin products, oral medications, and management solutions you can do so with Inven. This list was built with Inven and there are hundreds of companies like these globally.

With Inven you'll also get to know the company's:

  • Detailed Ownership: Who owns the company? Is it a public or private company? What is the ownership structure?
  • Contact data: Who are the founders and CEO's? What are their emails and phone numbers?
  • Financials: How do these companies perform financially? What are their revenues and profit margins?

...and a lot more!

Find companies 10x faster with Inven
Mock-up images of Inven UIGet started

Trusted by 900+ companies

Keep on reading

More articles